Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Safety Statement
For laboratory research and development purposes only.
Regulatory & Compliance
Specifications
COUNTRY OF ORIGIN
China
GENE ID
https://www.ncbi.nlm.nih.gov/gene/899;
*USAGE / SAFETY STATEMENT
For laboratory research and development purposes only.
MWCO (kDa)
88kd
APPLICATION.1
WB IHC
ANTIBODY TYPE
Polyclonal
HOST SPECIES
Rabbit
REACTIVITY SPECIES
Hu
PURIFICATION
Antigen affinity purification.
GENE ALIAS
CCNF
IMMUNOGEN
Fusion protein corresponding to residues near the C terminal of human cyclin F
SPECIFICITY
The antibody detects endogenous levels of total CCNF protein.
SWISS-PROT NO.
P41002
BACKGROUND
This gene encodes a member of the cyclin family. Cyclins are important regulators of cell cycle transitions through their ability to bind and activate cyclin-dependent protein kinases. This member also belongs to the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of the ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbxs class and it was one of the first proteins in which the F-box motif was identified.
ALTERNAME
FBX1; FBXO1
FORM OF ANTIBODY
Rabbit IgG in pH7.4 PBS, 0.05% NaN3, 40% Glycerol.
RECOMMENDED DILUTIONS
Western blotting: 1:200-1:1000<br/>Immunohistochemistry: 1:25-1:100
Questions & Answers (0)
Citations (0)
Shipping & Handling
Shipped In
Cold Packs
Safety & Storage
Storage Temperature
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Safety Statement
For laboratory research and development purposes only.
Regulatory & Compliance
We’re currently in BETA - Interested in joining? Let us know and we’ll get you set up with early access.